Please provide your email address to receive an email when new articles are posted on . A Bay Area bioelectronic medicine company announced the commercial launch of its next-generation Cala kIQ System ...
A groundbreaking international clinical trial has been testing an implanted adaptive deep brain stimulation (aDBS) device as a treatment therapy for Parkinson’s.
With the introduction of adaptive deep brain stimulation (aDBS) for Parkinson's disease, new questions emerge regarding who, why, and how to treat. This paper outlines the pathophysiological rationale ...
BURLINGAME, Calif.--(BUSINESS WIRE)--Cala Health, Inc., a bioelectronic medicine company developing wearable therapies for chronic disease, announced that the U.S. Food and Drug Administration (FDA) ...
A new discovery paves the way for clinical trials that use patients' own cells to treat Parkinson's disease. Scientists from Scripps Research and Cardiff University made key discoveries in support of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results